This federal contract award, valued at $17,647.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract covers the delivery of IPOL VIAL 5ML, a pharmaceutical product, to support federal healthcare requirements. No set-aside designation was used for this award. Amerisourcebergen, as the prime contractor, will be responsible for fulfilling the order, which has a completion date of December 27, 2024. This contract award demonstrates Amerisourcebergen's ongoing role as a key vendor for the DLA and other federal agencies, providing essential medical commodities and supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/30/25, 12:45 AM